Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | NT5E | P21589 | 2/20 | 0.59 |
| ▸ | RELA | Q04206 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | TOP2A | P11388 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | PTGES | O14684 | 1/20 | 0.54 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.49 |
| ▸ | F3 | P13726 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | GLI1 | P08151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5439844 | 1.00 | LMNA (0.59) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL14398330 | 1.00 | LMNA (0.59) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL13910800 | 0.93 | LMNA (0.50) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL13910941 | 0.92 | LMNA (0.49) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL13910934 | 0.91 | LMNA (0.48) | LMNANT5ERELAUSP2HIF1A | |
| Glochidone SCHEMBL31721106 | 0.86 | PTPN1 (0.56) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL13910802 | 0.86 | LMNA (0.43) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL6112812 | 0.85 | GPBAR1 (0.66) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL6715660 | 0.84 | LMNA (0.58) | LMNANT5ERELAUSP2HIF1A | |
| SCHEMBL7747717 | 0.84 | LMNA (0.58) | LMNANT5ERELAUSP2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090062243-A1 | Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof | ADVANCED LIFE SCIENCES, INC. (US) | 2009-03-05 | — | — | US | disclosed |
| US-20070232577-A1 | Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin | ADVANCED LIFE SCIENCES, INC. (US) | 2007-10-04 | — | — | US | disclosed |
| US-20070232577-A1 | Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin | ADVANCED LIFE SCIENCES, INC. (US) | 2007-10-04 | — | — | US | disclosed |
| WO-2007112043-A2 | SYNTHETIC PENTACYCLIC TRITERPENOIDS AND DERIVATIVES OF BETULINIC ACID AND BETULIN | ADVANCED LIFE SCIENCES INC. (US) | 2007-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232577-A1 | Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin | BET1, PGGT1B, BRCA1 | LMNA 4313/4885NT5E 3553/4885RELA 449/4885 |
| US-20090062243-A1 | Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof | BRCA1, PGF, GPER1 | LMNA 352/4885NT5E 4069/4885RELA 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.